Back
Speaker illustration

Professor Ellie Kelepouris

University of Pennsylvania, Philadelphia (United States of America)

Presentations

Optimisation of renin-angiotensin-aldosterone system inhibitors use in chronic kidney disease patients with heart failure: is hyperkalaemia a barrier?

Event: Heart Failure 2025

Topic: Pharmacotherapy

Session: Congestion, SGLT2 inhibitors and novel therapies

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources